Medications starting with
Poland-
It is used in the treatment of high blood pressure, angina pectoris, irregular heart rhythm (arrhythmia), palpitations, and chronic heart failure. It also helps to prevent another myocardial infarction and migraine attacks.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 47.5 mg ATC code: C07AB02
Manufacturer: Recordati Ireland Ltd
-
The medicine is used to treat high blood pressure (hypertension), angina pectoris, irregular heart rhythm (arrhythmia), and palpitations. It also helps in the treatment of chronic heart failure and in preventing another myocardial infarction (heart attack) or migraine attacks.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 47.5 mg ATC code: C07AB02
Manufacturer: Recordati Industria Chimica e Farmaceutica S.p.A
-
The medicine is used in the treatment of high blood pressure (hypertension), angina pectoris, irregular heart rhythm (arrhythmia), palpitations, and chronic heart failure. It also helps to prevent further myocardial infarctions (heart attacks) and migraine attacks.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 47.5 mg ATC code: C07AB02
Manufacturer: Recordati Ireland Ltd
-
The medicine is used to treat symptoms of Ménière's disease, such as dizziness (accompanied by nausea and vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Biofarm Sp. z o.o.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare
-
It is used in the treatment of Ménière's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Neuraxpharm Spain S.L.U.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It is also used for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea and vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris GX BV
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Medical
-
The medicine is used to treat Meniere's disease (characterized by dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Limited
-
It is used in the treatment of Meniere's disease, which is characterized by dizziness (with nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris GX
-
The medicine is used to treat Meniere's disease (manifesting as dizziness with nausea or vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare Lda.
-
The medicine is used to treat Meniere's disease, which is characterized by dizziness (accompanied by nausea or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris GX
-
The medicine is used in Meniere's disease (manifesting as dizziness, nausea, vomiting, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Delpharm L'Aigle
-
The medicine is used in Meniere's disease (manifesting, among other things, as dizziness, nausea, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
It is used in Meniere's disease (manifesting, among other things, as dizziness, nausea, tinnitus, or hearing loss) and in dizziness caused by abnormal function of the part of the inner ear responsible for balance.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Viatris Healthcare, Lda.
-
The medicinal product is used in adults for the treatment of mild to moderate arterial hypertension and for the long-term treatment and prevention of attacks of stable exertional angina pectoris.
Dosage form: tablets
Active substance Dosage betaxolol hydrochloride 20 mg ATC code: C07AB05
Manufacturer: Pharmazet Group s.r.o. Saneca Pharmaceuticals a. s.
-
The medicine is intended for adults for the treatment of mild to moderate arterial hypertension and for the long-term prevention of attacks of stable exertional angina pectoris.
Dosage form: tablets
Active substance Dosage betaxolol hydrochloride 20 mg ATC code: C07AB05
Manufacturer: PRO.MED.CS. Praha Ltd.
-
The medicine is used in adults to treat mild or moderate arterial hypertension and for the long-term prevention of attacks of stable angina pectoris.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC code: C07AB05
Manufacturer: Delpharm Reims
-
The medicine is used in the treatment of depression (major depressive episodes) and various anxiety disorders, such as social phobia, generalized anxiety disorder, obsessive-compulsive disorder, and panic disorder.
Dosage form: tablets, film-coated
Active substance Dosage escitalopram 10 mg ATC code: N06AB10
Manufacturer: Heumann Pharma GmbH Pharmadox Healthcare Ltd.
-
The medicine is intended for adults for the treatment of depression (major depressive episodes) and various anxiety disorders, such as social phobia, generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder.
Dosage form: drops, oral solution
Active substance Dosage escitalopram 20 mg/ml ATC code: N06AB10
Manufacturer: Heumann Pharma GmbH & Co. Generica KG
-
The medicine is used topically for the treatment of many skin diseases, such as: atopic dermatitis, nummular eczema, scabies nodules, psoriasis (excluding generalized lesions), chronic lichen simplex chronicus and lichen planus, seborrheic dermatitis, allergic or contact dermatitis, discoid lupus erythematosus, and severe reactions to insect bites.
Dosage form: cream
Active substance Dosage betamethasone valerate No input provided ATC code: D07AC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used topically for the treatment of skin diseases that respond to corticosteroids, such as: atopic dermatitis, nummular eczema, scabies nodularis, psoriasis (excluding generalized lesions), chronic lichen simplex chronicus and lichen planus, seborrheic dermatitis, allergic or contact dermatitis, discoid lupus erythematosus, and severe reactions to insect bites.
Dosage form: ointment
Active substance Dosage betamethasone valerate No input provided ATC code: D07AC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used topically to treat skin diseases that respond to corticosteroids and are accompanied by bacterial or fungal infection. It helps, among others, in atopic dermatitis, eczema, psoriasis, lichen, seborrheic dermatitis, and in severe reactions to insect bites.
Dosage form: ointment
Active substance Dosage betamethasone valerate 1.22 mg/g clioquinol 30 mg/g ATC code: D07BC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used topically to treat skin diseases that respond to steroids and are accompanied by bacterial or fungal infection. This includes, among others, atopic dermatitis, eczema, psoriasis, lichen, seborrheic dermatitis, and severe reactions to insect bites.
Dosage form: cream
Active substance Dosage betamethasone valerate 1.22 mg/g clioquinol 30 mg/g ATC code: D07BC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used topically to treat corticosteroid-responsive skin diseases accompanied by or secondary to bacterial infection. This includes, among others, atopic dermatitis, eczema (nummular, contact), psoriasis, lichen planus, seborrheic dermatitis, severe insect bite reactions, and impetigo.
Dosage form: cream
Active substance Dosage betamethasone valerate 1.22 mg/g neomycin sulfate 5 mg/g ATC code: D07CC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used topically for the treatment of skin diseases that respond to corticosteroids and have an associated or secondary bacterial infection. This includes, among others, atopic dermatitis, eczema (nummular, contact), psoriasis (excluding generalized lesions), scabies nodules, lichen planus, seborrheic dermatitis, severe reactions to insect bites, and diaper dermatitis in the perianal and genital areas.
Dosage form: ointment
Active substance Dosage betamethasone valerate 1.22 mg/g neomycin sulfate 5 mg/g ATC code: D07CC01
Manufacturer: Delpharm Poznan S.A.
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including rapid heart rate), and heart failure. It is also used for prophylaxis after a myocardial infarction, for heart palpitations, and for migraine prevention. In children and adolescents (6–18 years), it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: Hexal AG
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including rapid heart rate), and heart failure. It is also used for prophylaxis after a myocardial infarction, for the unpleasant sensation of a strong or irregular heartbeat, and for migraine prevention. In children and adolescents, it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: Hexal AG
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including accelerated heart rate), and heart failure. It is also used for prophylaxis after a myocardial infarction, for heart palpitations, and for migraine prevention. In children and adolescents (6–18 years), it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: 1 A Pharma GmbH
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including rapid heart rate), heart failure, and for prophylaxis after a myocardial infarction. It also helps with the unpleasant sensation of a strong or irregular heartbeat and in the prevention of migraines.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: Hexal Pharma GmbH
-
The medicine is used to treat high blood pressure, chest pain (angina pectoris), heart rhythm disorders, and for prophylaxis after a myocardial infarction. It also helps with the unpleasant sensation of a racing heart and in the prevention of migraines. In children and adolescents (6–18 years), it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: 1 A Pharma GmbH
-
It is used in the treatment of high blood pressure, chest pain, cardiac arrhythmias (including tachycardia), and heart failure. It also helps in the prevention of migraines, when experiencing palpitations, and for prophylaxis following a myocardial infarction.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: HEXAL AG
-
The medicine is used to treat high blood pressure, chest pain (angina pectoris), heart rhythm disorders, and for prophylaxis after a myocardial infarction. It also helps with heart failure, palpitations, and in the prevention of migraines. In children and adolescents, it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 95 mg ATC code: C07AB02
Manufacturer: 1 A Pharma GmbH
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including rapid heartbeat), and heart failure. It also helps in prevention after a myocardial infarction (heart attack), for unpleasant sensations of a strong or irregular heartbeat, and in migraine prevention. In children and adolescents (6–18 years), it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 142.5 mg ATC code: C07AB02
Manufacturer: Hexal AG
-
It is used in the treatment of high blood pressure, chest pain, cardiac arrhythmias (including rapid heartbeat), and heart failure. It also helps in the prevention of migraines and in prophylaxis following an acute myocardial infarction.
Dosage form: tablets, prolonged release
ATC code: C07AB02
Manufacturer: Hexal AG
-
It is used in the treatment of high blood pressure, chest pain, heart rhythm disorders (including rapid heart rate), heart failure, and for prophylaxis after a myocardial infarction. It also helps with the unpleasant sensation of a strong or irregular heartbeat and in the prevention of migraines.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 142.5 mg ATC code: C07AB02
Manufacturer: 1 A Pharma GmbH
-
The medicine is used to treat high blood pressure, chest or heart pain (angina pectoris), heart rhythm disorders, prophylaxis after a myocardial infarction, in cases of heart palpitations, and for migraine prevention. It is also used in mild to moderate heart failure.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 142.5 mg ATC code: C07AB02
Manufacturer: 1 A Pharma GmbH
-
The medicine is used to treat high blood pressure, chest pain, heart rhythm disorders (including rapid heart rate), and heart failure. It is also used for prophylaxis after a myocardial infarction, for heart palpitations, and for migraine prevention. In children and adolescents (6–18 years), it is used to treat arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 190 mg ATC code: C07AB02
Manufacturer: HEXAL AG
-
The drug is used in the treatment of high blood pressure, chest pain, cardiac arrhythmias (including tachycardia), prophylaxis after myocardial infarction, for the sensation of a strong or irregular heartbeat, in the treatment of heart failure, and for migraine prevention. In children and adolescents, it is used for the treatment of arterial hypertension.
Dosage form: tablets, prolonged release
Active substance Dosage metoprolol succinate 190 mg ATC code: C07AB02
Manufacturer: Sandoz B.V.